Tata Chemicals Limited has informed the Exchange about Copy of Newspaper Publication
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tata Chemicals has published its Q2 and H1 FY26 financial results (quarter and half year ended September 30, 2025) in Financial Express, The Free Press Journal, and Navshakti on November 2, 2025, as approved by the Board on November 1, 2025. On a consolidated basis, revenue from continuing operations fell to ₹3,877 crore in Q2 from ₹3,999 crore a year ago, while profit after tax dropped sharply to ₹154 crore from ₹267 crore. H1 FY26 consolidated PAT, however, rose modestly to ₹470 crore from ₹442 crore, with EPS at ₹3.02 for the quarter. On a standalone basis, revenue grew to ₹1,204 crore (from ₹1,009 crore) and PAT jumped to ₹178 crore (from ₹99 crore), with EPS of ₹6.99. Net worth stood at ₹23,331 crore with a debt-to-equity ratio of 0.32.
Mixed quarter for shareholders — consolidated profits declined sharply year-on-year, but the standalone business (parent company) showed strong growth, and H1 consolidated earnings were slightly better than last year. The stock may react to the weak consolidated Q2 print, though the healthy standalone performance provides some comfort.